News Releases :: Sutro Biopharma, Inc. (STRO)

Oct 23, 2014 7:30 am EDT

Sutro Biopharma and Celgene Corporation Enter Multi-Year Strategic Collaboration and Option to Acquire Agreement

Sep 22, 2014 8:00 am EDT

FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014

Sep 17, 2014 8:00 am EDT

Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates

Sep 9, 2014 9:00 am EDT

Sutro Biopharma to Collaborate with University of California, San Francisco (UCSF), a Recombinant Antibody Network (RAN) Member

Mar 24, 2014 9:00 am EDT

Sutro Biopharma to Present at 21st Annual Future Leaders in the Biotech Industry Conference

Jan 7, 2014 9:00 am EST

Sutro Biopharma to Collaborate With Memorial Sloan-Kettering Cancer Center to Produce Bispecific Antibodies for the Treatment of Neuroblastoma

Dec 11, 2013 9:00 am EST

Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products

Oct 15, 2013 2:00 pm EDT

Sutro Biopharma Presents Dual-Warhead Antibody Drug Conjugate at the World ADC Summit

Jan 31, 2013 9:00 am EST

Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer

Jan 3, 2013 9:00 am EST

Sutro Biopharma to Collaborate with Sanofi Pasteur on a Novel Production Approach for Vaccine Candidates